BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 17132649)

  • 1. Impact of C-reactive protein and fibrinogen on cardiovascular prognosis in patients with stable angina pectoris: the AtheroGene study.
    Sinning JM; Bickel C; Messow CM; Schnabel R; Lubos E; Rupprecht HJ; Espinola-Klein C; Lackner KJ; Tiret L; Münzel T; Blankenberg S;
    Eur Heart J; 2006 Dec; 27(24):2962-8. PubMed ID: 17132649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of N-terminal-pro-brain natriuretic peptide and C-reactive protein for risk stratification in stable and unstable coronary artery disease: results from the AtheroGene study.
    Schnabel R; Rupprecht HJ; Lackner KJ; Lubos E; Bickel C; Meyer J; Münzel T; Cambien F; Tiret L; Blankenberg S;
    Eur Heart J; 2005 Feb; 26(3):241-9. PubMed ID: 15618051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Haemostatic factors and the risk of cardiovascular death in patients with coronary artery disease: the AtheroGene study.
    Morange PE; Bickel C; Nicaud V; Schnabel R; Rupprecht HJ; Peetz D; Lackner KJ; Cambien F; Blankenberg S; Tiret L;
    Arterioscler Thromb Vasc Biol; 2006 Dec; 26(12):2793-9. PubMed ID: 17023678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. B-type natriuretic peptide and the risk of cardiovascular events and death in patients with stable angina: results from the AtheroGene study.
    Schnabel R; Lubos E; Rupprecht HJ; Espinola-Klein C; Bickel C; Lackner KJ; Cambien F; Tiret L; Münzel T; Blankenberg S
    J Am Coll Cardiol; 2006 Feb; 47(3):552-8. PubMed ID: 16458135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of C-reactive protein, fibrinogen and antithrombin-III as risk factors for coronary artery disease.
    Cavusoglu Y; Gorenek B; Alpsoy S; Unalir A; Ata N; Timuralp B
    Isr Med Assoc J; 2001 Jan; 3(1):13-6. PubMed ID: 11344793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-6 and the risk of future cardiovascular events in patients with angina pectoris and/or healed myocardial infarction.
    Fisman EZ; Benderly M; Esper RJ; Behar S; Boyko V; Adler Y; Tanne D; Matas Z; Tenenbaum A
    Am J Cardiol; 2006 Jul; 98(1):14-8. PubMed ID: 16784912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group.
    Thompson SG; Kienast J; Pyke SD; Haverkate F; van de Loo JC
    N Engl J Med; 1995 Mar; 332(10):635-41. PubMed ID: 7845427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of adiponectin with adverse outcome in coronary artery disease patients: results from the AtheroGene study.
    Schnabel R; Messow CM; Lubos E; Espinola-Klein C; Rupprecht HJ; Bickel C; Sinning C; Tzikas S; Keller T; Genth-Zotz S; Lackner KJ; Münzel TF; Blankenberg S
    Eur Heart J; 2008 Mar; 29(5):649-57. PubMed ID: 18263867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of tissue inhibitor of metalloproteinase-1 for cardiovascular death among patients with cardiovascular disease: results from the AtheroGene study.
    Lubos E; Schnabel R; Rupprecht HJ; Bickel C; Messow CM; Prigge S; Cambien F; Tiret L; Münzel T; Blankenberg S
    Eur Heart J; 2006 Jan; 27(2):150-6. PubMed ID: 16230310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Usefulness of preoperative C-reactive protein and soluble intercellular adhesion molecule-1 level for predicting future cardiovascular events after coronary artery bypass grafting.
    van der Harst P; Voors AA; Volbeda M; Buikema H; van Veldhuisen DJ; van Gilst WH
    Am J Cardiol; 2006 Jun; 97(12):1697-701. PubMed ID: 16765116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased thrombin generation after acute versus chronic coronary disease as assessed by the thrombin generation test.
    Orbe J; Zudaire M; Serrano R; Coma-Canella I; Martínez de Sizarrondo S; Rodríguez JA; Páramo JA
    Thromb Haemost; 2008 Feb; 99(2):382-7. PubMed ID: 18278189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term prognostic significance of high-sensitivity C-reactive protein before and after coronary angioplasty in patients with stable angina pectoris.
    Gach O; Legrand V; Biessaux Y; Chapelle JP; Vanbelle S; Pierard LA
    Am J Cardiol; 2007 Jan; 99(1):31-5. PubMed ID: 17196457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating soluble adhesion molecules ICAM-1 and VCAM-1 and their association with clinical outcome, troponin T and C-reactive protein in patients with acute coronary syndromes.
    Postadzhiyan AS; Tzontcheva AV; Kehayov I; Finkov B
    Clin Biochem; 2008 Feb; 41(3):126-33. PubMed ID: 18061588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of the Centers for Disease Control/American Heart Association high-sensitivity C-reactive protein cut points for cardiovascular and other outcomes in patients with stable coronary artery disease.
    Sabatine MS; Morrow DA; Jablonski KA; Rice MM; Warnica JW; Domanski MJ; Hsia J; Gersh BJ; Rifai N; Ridker PM; Pfeffer MA; Braunwald E;
    Circulation; 2007 Mar; 115(12):1528-36. PubMed ID: 17372173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated serum neopterin predicts future adverse cardiac events in patients with chronic stable angina pectoris.
    Avanzas P; Arroyo-Espliguero R; Quiles J; Roy D; Kaski JC
    Eur Heart J; 2005 Mar; 26(5):457-63. PubMed ID: 15684278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of circulating pregnancy-associated plasma protein levels in patients with chronic stable angina.
    Elesber AA; Conover CA; Denktas AE; Lennon RJ; Holmes DR; Overgaard MT; Christiansen M; Oxvig C; Lerman LO; Lerman A
    Eur Heart J; 2006 Jul; 27(14):1678-84. PubMed ID: 16717071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of traditional and novel risk factors on the relationship between socioeconomic status and incident cardiovascular events.
    Albert MA; Glynn RJ; Buring J; Ridker PM
    Circulation; 2006 Dec; 114(24):2619-26. PubMed ID: 17116764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Additive value of immunoassay-measured fibrinogen and high-sensitivity C-reactive protein levels for predicting incident cardiovascular events.
    Mora S; Rifai N; Buring JE; Ridker PM
    Circulation; 2006 Aug; 114(5):381-7. PubMed ID: 16864722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of plasma osteopontin levels in patients with chronic stable angina.
    Minoretti P; Falcone C; Calcagnino M; Emanuele E; Buzzi MP; Coen E; Geroldi D
    Eur Heart J; 2006 Apr; 27(7):802-7. PubMed ID: 16421174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased levels of C-reactive protein and fibrinogen influence the risk of vascular events in patients with NIDDM.
    Coppola G; Corrado E; Muratori I; Tantillo R; Vitale G; Lo Coco L; Novo S
    Int J Cardiol; 2006 Jan; 106(1):16-20. PubMed ID: 16321660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.